Category - Developments

Developments

Aquinox Pharma AQX-1125 fails Phase 3 trial

Aquinox Pharmaceuticals (NASDAQ:AQXP) announced that the Phase 3 LEADERSHIP 301 clinical trial, evaluating once-daily, oral rosiptor (AQX-1125) for the treatment of interstitial cystitis/bladder pain syndrome, failed to...

June 27, 2018

Developments

IntelGenx receives notice of European patent grant for Rizaport VersaFilm

IntelGenx (TSXV:IGX; OTCQX:IGXT) said the European Patent Office (EPO) has issued a notice of intention to grant the first key patent allowed in Europe for the company’s VersaFilm technology. The patent is entitled...

June 19, 2018

Developments

Ortho RTi posts positive rotator cuff repair data

Ortho Regenerative Technologies (CSE:ORTH) reported positive outcomes data from a study examining its Ortho-R technology in the biologic repair of rotator cuff injuries. Conducted by researchers from Montreal’s École...

June 13, 2018

Developments

IntelGenx Montelukast VersaFilm featured in peer-reviewed journal

IntelGenx (TSXV:IGX; OTCQX:IGXT) announced that a peer-reviewed paper entitled, “2018 Alzheimer’s Disease Facts and Figures,” published in the March 2018 issue of Alzheimer’s & Dementia: The Journal of the...

June 6, 2018

Developments

Titan Pharma, Braeburn terminate Probuphine license agreement

Titan Pharmaceuticals (NASDAQ:TTNP) and Braeburn agreed to terminate a December 2012 license agreement, which granted Braeburn exclusive rights to commercialize Probuphine in the U.S. and Canada. Under the...

May 30, 2018

Developments

Ortho RTi receives European patent allowance

Ortho Regenerative Technologies (CSE:ORTH) received a notice of allowance from the European Patent Office for a patent entitled, “Soluble Physiological Chitosan Formulations Combined with Platelet-Rich Plasma...

May 23, 2018

Developments

Cara Therapeutics licenses KORSAUVA to Vifor Fresenius JV

Cara Therapeutics (NASDAQ:CARA) licensed worldwide rights, except in the U.S., Japan and South Korea, to commercialize KORSUVA injection for the treatment of chronic kidney disease-associated pruritus (CKD-aP) in...

May 23, 2018

Developments

Beta Bionics receives FDA go-ahead for home trials of AI-guided bionic pancreas

Closely-held Beta Bionics received FDA approval to begin home-use clinical studies of an autonomous bionic pancreas that employs artificial intelligence to vary hormone doses in adults and children with Type 1 diabetes...

May 22, 2018

Developments

Nabriva posts positive pivotal results in second CABP trial

Nabriva Therapeutics (NASDAQ:NBRV) reported positive top-line results from its LEAP 2 clinical trial, the second of two global, Phase 3 clinical trials of its antibiotic, lefamulin. LEAP 2 evaluated the safety and...

May 22, 2018

Developments

Tear Film Innovations closes Series B financing

Closely-held Tear Film Innovations completed an $8.5-million Series B preferred stock round led by Visionary Ventures Fund and Bluestem Capital. “This successful funding round completes the capitalization for our growth...

May 22, 2018

Category - Developments

Aquinox Pharma AQX-1125 fails Phase 3 trial

IntelGenx receives notice of European patent grant for Rizaport VersaFilm

Ortho RTi posts positive rotator cuff repair data

IntelGenx Montelukast VersaFilm featured in peer-reviewed journal

Titan Pharma, Braeburn terminate Probuphine license agreement

Ortho RTi receives European patent allowance

Cara Therapeutics licenses KORSAUVA to Vifor Fresenius JV

Beta Bionics receives FDA go-ahead for home trials of AI-guided bionic pancreas

Nabriva posts positive pivotal results in second CABP trial

Tear Film Innovations closes Series B financing

General

More